Dr. Kristina Roddy, MD
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,373 | 505 | 97.8% |
| Education | $232.56 | 11 | 2.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ViiV Healthcare Company | $2,378 | 117 | $0 (2024) |
| Merck Sharp & Dohme LLC | $1,781 | 95 | $0 (2024) |
| Gilead Sciences, Inc. | $1,503 | 80 | $0 (2024) |
| Astellas Pharma US Inc | $888.10 | 41 | $0 (2024) |
| Janssen Biotech, Inc. | $768.60 | 42 | $0 (2023) |
| Allergan, Inc. | $537.43 | 28 | $0 (2020) |
| ABBVIE INC. | $484.18 | 20 | $0 (2024) |
| Theravance Biopharma, Inc. | $425.95 | 9 | $0 (2018) |
| Insmed, Inc. | $368.92 | 18 | $0 (2024) |
| Theratechnologies Inc. | $341.94 | 15 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,844 | 74 | ViiV Healthcare Company ($687.76) |
| 2023 | $1,407 | 62 | Gilead Sciences, Inc. ($205.32) |
| 2022 | $712.14 | 34 | ViiV Healthcare Company ($230.84) |
| 2021 | $953.14 | 51 | Merck Sharp & Dohme Corporation ($223.84) |
| 2020 | $1,368 | 68 | ViiV Healthcare Company ($442.82) |
| 2019 | $1,443 | 79 | Merck Sharp & Dohme Corporation ($288.67) |
| 2018 | $1,058 | 62 | Merck Sharp & Dohme Corporation ($236.93) |
| 2017 | $1,821 | 86 | Theravance Biopharma Inc. ($390.40) |
All Payment Transactions
516 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | ViiV Healthcare Company | RUKOBIA (Drug) | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: HIV | ||||||
| 12/20/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $32.64 | General |
| Category: HIV | ||||||
| 12/12/2024 | ABBVIE INC. | AVYCAZ (Drug), DALVANCE, TEFLARO | Food and Beverage | In-kind items and services | $19.42 | General |
| Category: ANTI-INFECTIVE | ||||||
| 12/10/2024 | Merck Sharp & Dohme LLC | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 12/10/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $5.24 | General |
| 12/03/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $20.41 | General |
| 12/03/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $9.91 | General |
| 11/26/2024 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $24.81 | General |
| Category: Infections and Infectious Diseases | ||||||
| 11/21/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $34.99 | General |
| 11/21/2024 | Astellas Pharma US Inc | Cresemba (Drug) | Food and Beverage | In-kind items and services | $32.98 | General |
| Category: Infectious Diseases | ||||||
| 11/15/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $28.84 | General |
| Category: HIV | ||||||
| 11/12/2024 | Merck Sharp & Dohme LLC | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $26.52 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/08/2024 | ViiV Healthcare Company | RUKOBIA (Drug) | Food and Beverage | In-kind items and services | $24.50 | General |
| Category: HIV | ||||||
| 11/07/2024 | Theratechnologies Inc. | EGRIFTA (Drug), TROGARZO | Food and Beverage | In-kind items and services | $31.52 | General |
| Category: HIV | ||||||
| 11/05/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.66 | General |
| 10/31/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: HIV | ||||||
| 10/29/2024 | Astellas Pharma US Inc | Cresemba (Drug) | Food and Beverage | In-kind items and services | $33.98 | General |
| Category: Infectious Diseases | ||||||
| 10/18/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $24.46 | General |
| Category: Respiratory | ||||||
| 10/18/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $24.45 | General |
| Category: Respiratory | ||||||
| 10/15/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $20.81 | General |
| Category: HIV | ||||||
| 10/10/2024 | ABBVIE INC. | DALVANCE (Drug), AVYCAZ, TEFLARO | Food and Beverage | In-kind items and services | $30.55 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/04/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $28.28 | General |
| Category: HIV | ||||||
| 10/03/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $28.69 | General |
| 10/02/2024 | Astellas Pharma US Inc | Cresemba (Drug) | Food and Beverage | In-kind items and services | $7.37 | General |
| Category: Infectious Diseases | ||||||
| 09/19/2024 | Melinta Therapeutics, LLC | Rezzayo (Drug), Kimyrsa, Orbactiv | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: ANTIFUNGALS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 317 | 475 | $110,046 | $44,339 |
| 2022 | 6 | 360 | 540 | $107,680 | $49,860 |
| 2021 | 6 | 349 | 534 | $107,130 | $51,564 |
| 2020 | 8 | 416 | 610 | $127,595 | $61,352 |
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 67 | 149 | $28,380 | $13,888 | 48.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 88 | 97 | $39,276 | $13,179 | 33.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 66 | 114 | $16,605 | $7,065 | 42.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 42 | 43 | $11,900 | $4,377 | 36.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 25 | 36 | $8,010 | $3,423 | 42.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 29 | 36 | $5,875 | $2,406 | 41.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 98 | 232 | $36,000 | $18,492 | 51.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 94 | 104 | $37,440 | $16,177 | 43.2% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 49 | 49 | $12,250 | $5,194 | 42.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 63 | 84 | $10,920 | $4,648 | 42.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 31 | 44 | $5,940 | $2,972 | 50.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 25 | 27 | $5,130 | $2,377 | 46.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 101 | 243 | $37,665 | $19,895 | 52.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 104 | 111 | $39,960 | $17,305 | 43.3% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 44 | 47 | $11,750 | $5,064 | 43.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 36 | 51 | $6,135 | $3,474 | 56.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 41 | 54 | $7,020 | $3,077 | 43.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 23 | 28 | $4,600 | $2,748 | 59.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 142 | 158 | $56,880 | $25,559 | 44.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 108 | 266 | $41,230 | $22,122 | 53.7% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 50 | 51 | $12,750 | $5,599 | 43.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 27 | 30 | $4,800 | $2,239 | 46.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 30 | 38 | $4,940 | $2,192 | 44.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 31 | 36 | $3,960 | $1,934 | 48.8% |
| G0181 | Physician supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician development and/or revision of c | Office | 2020 | 11 | 12 | $1,800 | $1,028 | 57.1% |
About Dr. Kristina Roddy, MD
Dr. Kristina Roddy, MD is a Student in an Organized Health Care Education/Training Program healthcare provider based in Albany, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/15/2007. The National Provider Identifier (NPI) number assigned to this provider is 1659415693.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kristina Roddy, MD has received a total of $10,606 in payments from pharmaceutical and medical device companies, with $1,844 received in 2024. These payments were reported across 516 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($10,373).
As a Medicare-enrolled provider, Roddy has provided services to 1,442 Medicare beneficiaries, totaling 2,159 services with total Medicare billing of $207,115. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Infectious Disease
- Location Albany, NY
- Active Since 02/15/2007
- Last Updated 06/11/2021
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1659415693
Products in Payments
- DOVATO (Drug) $1,524
- ZERBAXA (Drug) $773.40
- AVYCAZ (Drug) $705.34
- Cresemba (Drug) $398.82
- DIFICID (Drug) $381.04
- Arikayce (Drug) $368.92
- SYMTUZA (Drug) $336.91
- Symtuza (Drug) $275.31
- TRIUMEQ (Drug) $272.82
- CRESEMBA (Drug) $271.02
- RUKOBIA (Drug) $256.18
- PREZCOBIX (Drug) $241.08
- EGRIFTA (Drug) $240.08
- Fetroja (Drug) $239.89
- DALVANCE (Drug) $232.34
- ISENTRESS (Drug) $224.80
- JULUCA (Drug) $202.58
- VIBATIV (Drug) $197.10
- ATTUNE (Device) $144.57
- NUZYRA (Drug) $106.75
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Albany
Anuj Malhotra, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $224,738
Dr. Erica Parrotta, D.o, D.O
Student in an Organized Health Care Education/Training Program — Payments: $111,723
William Raible, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $42,671
Dr. Olumayowa Abiodun, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $33,199
Dr. Alexandra Paul, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $15,462
Dr. Sridhar Musuku, M.d Frca, M.D FRCA
Student in an Organized Health Care Education/Training Program — Payments: $14,736